Document:

exv10w6w1

Exhibit 10.6.1

VARIATION AGREEMENT

TO CO-DEVELOPMENT

AND COMMERCIALIZATION AGREEMENT

     THIS VARIATION AGREEMENT (“Variation Agreement”) is made and entered into as of the 19 day of
December, 2009 by and among Rules-Based Medicine, Inc., a Delaware corporation (“RBM”); and Psynova
Neurotech Limited, a company incorporated in England and Wales (“Psynova”).

W I T N E S S E T H:

     WHEREAS, RBM and Psynova are parties to that certain Co-Development and Commercialization
Agreement dated September 5, 2008 (as amended and varied, the “Agreement”) whereby, among other
things, Psynova granted certain rights to RBM under Section 9.3 of the Agreement (the
“Schizophrenia IP Rights”);

     WHEREAS, the Schizophrenia IP Rights include rights under any Psynova Background IP (as
defined in the Agreement), which includes Intellectual Property (as defined in the Agreement”) that
is related to a Schizophrenia Product (as defined in this Agreement) that is subject to the
Framework Agreement between The Chancellor, Masters and Scholars of the University of Cambridge,
Cambridge Enterprise Limited, and Psynova (the “Framework Agreement”); and

     WHEREAS, Psynova has certain rights to the intellectual property set forth in Schedule 1,
which is subject to the Framework Agreement and the parties desire to amend the Agreement to
memorialize the inclusion of said intellectual property within the Schizophrenia IP rights granted
to RBM under the Agreement.

     NOW, THEREFORE, in consideration of the foregoing and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby
agree as follows:

     1. Definitions. Capitalized terms used but not defined herein shall have the meaning
given in the Agreement.

     2. Amendments to Agreement.

     (a) Psynova Background IP. The definition of Psynova Background IP is hereby
deleted in its entirety and replaced with the following:

“Psynova Background IP” means (a) any Intellectual Property owned, licensed to
or developed by Psynova independently of the R&D Project and this Agreement,
which relates to any Schizophrenia Product, and (b) the Intellectual Property
identified in Schedule 1 hereto, which relates to any Schizophrenia
Product.

     (b) Inventions. The definition of Invention is hereby deleted in its entirety
and replaced with the following:

 

 

“Invention” means (a) an invention conceived by one or more employee or agent
of either Psynova or RBM or the parties jointly, which invention arises from
the R&D Project or otherwise under the terms of this Agreement, and includes
without limitation all New Biomarkers and New Assays and (b) an invention
owned, licensed to or developed by Psynova independently of the R&D Project
and this Agreement, which relates to any Schizophrenia Product (such as
Intellectual Property licensed to Psynova as contemplated by the Framework
Agreement), and includes without limitation, the Inventions identified in
Schedule 2.

     3. Confirmation

The parties agree and declare that the Agreement shall (save as amended by this Variation
Agreement) continue in full force and effect and this Variation Agreement shall be read as one
with, and shall be supplemental to, the Agreement. Where there is any inconsistency or ambiguity
between the terms of the Agreement and this Variation Agreement, the terms of this Variation
Agreement shall prevail.

     4. Miscellaneous Provisions

	 	a.	 	The provisions of clauses 22 and 23.11 of the Agreement shall apply mutatis
mutandis.
	 
	 	b.	 	This Variation Agreement is not intended to confer any legally enforceable
rights on any person other than the parties, their successors in title and assignees,
whether pursuant to the Contracts (Rights of Third Parties) Act 1999 applicable to
England and Wales or otherwise.
	 
	 	c.	 	Each party acknowledges to the others (and shall execute this Variation
Agreement in reliance on such acknowledgement) that it has not been induced to enter
into this Variation Agreement by, nor relied on, any representation or warranty.
	 
	 	d.	 	This Variation Agreement may be executed in any number of counterparts and by
the different parties hereto in separate counterparts, each of which when so executed
shall be deemed to be an original and all of which taken together shall constitute one
and the same agreement. Delivery of an executed counterpart of a signature page to
this Variation Agreement by fax or email shall be effective as delivery of a manually
executed counterpart of this Variation Agreement.

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Variation Agreement as of the date
first set forth above.

	 	 	 	 	 
	 	RULES-BASED MEDICINE, INC.

 	 
	 	By:  	/s/  Samuel T. LaBrie
 	 
	 	Title:	 Vice President — Corporate Development 	 
	 	 	 	 
	 	PSYNOVA NEUROTECH LIMITED

 	 
	 	By:  	/s/ Paul Rodgers
 	 
	 	Title:	 Director 	 
	 	 	 	 
	 

 

 

SCHEDULE 1 TO CO-DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

Assigned to Cambridge and Subject to Framework Agreement with Psynova

	 	 	 	 	 	 	 	 	 
	Country	 	 	Application Number	 	Filing Date	 	Description
	 
	PCT

	 	 	PCT/GB2006/050034
	 	2/14/2006
	 	Bah-1253-01-Biomarkers and targets-psychiatric disorders/related disorders of CNS
	Australia

	 	 	2006212041	 	 	2/14/2006
	 	Bah-1253-01-Biomarkers and targets-psychiatric disorders/related disorders of CNS
	Canada

	 	 	2594405	 	 	2/14/2006
	 	Bah-1253-01-Biomarkers and targets-psychiatric disorders/related disorders of CNS
	China

	 	 	200680004894.5	 	 	2/14/2006
	 	Bah-1253-01-Biomarkers and targets-psychiatric disorders/related disorders of CNS
	Japan

	 	 	2007553715	 	 	2/14/2006
	 	Bah-1253-01-Biomarkers and targets-psychiatric disorders/related disorders of CNS
	Europe

	 	 	06710158	 	 	2/14/2006
	 	Bah-1253-01-Biomarkers and targets-psychiatric disorders/related disorders of CNS
	PCT

	 	 	PCT/GB2007/003090
	 	8/15/2007
	 	Bah-1677-06 – Diagnosing, monitoring, screening for major depressive order
	Australia

	 	 	2007285632	 	 	2/4/2009 (National Entry Date)
	 	Bah-1677-06 – Diagnosing, monitoring, screening for major depressive order
	Europe

	 	 	EP20070789213
	 	8/15/2007
	 	Bah-1677-06 – Diagnosing, monitoring, screening for major depressive order
	Japan

	 	 	2009524229	 	 	8/15/2007
	 	Bah-1677-06 – Diagnosing, monitoring, screening for major depressive order
	GB

	 	 	GB0521098.4
	 	10/18/2005
	 	Bah-1487-05 – Biomarkers and targets-psychiatric disorders/related disorders of CNS
	PCT

	 	 	PCT/GB2006/003870
	 	10/18/2006
	 	Bah-1487-05 – Biomarkers and targets-psychiatric disorders/related disorders of CNS
	Australia

	 	 	2006303026	 	 	11/4/2008 (National Entry)
	 	Bah-1487-05 – Biomarkers and targets-psychiatric disorders/related disorders of CNS
	Canada

	 	 	2626490	 	 	4/17/2008 (National Entry)
	 	Bah-1487-05 – Biomarkers and targets-psychiatric disorders/related disorders of CNS
	European

	 	 	2006794812	 	 	10/18/2006
	 	Bah-1487-05 – Biomarkers and targets-psychiatric disorders/related disorders of CNS
	US

	 	 	12/090,530	 	 	2/22/2009
	 	Bah-1487-05 – Biomarkers and targets-psychiatric disorders/related disorders of CNS
	PCT

	 	 	PCT/GB2006/004509
	 	4/12/2006
	 	Bah-1546-05 and Bah-1737-06 – biomarkers for psychotic disorders
	Australia

	 	 	2006321389	 	 	06/02/2008 (National Entry Date)
	 	Bah-1546-05 and Bah-1737-06 – biomarkers for psychotic disorders
	Canada

	 	 	2640846	 	 	05/29/2008 (National Entry Date)
	 	Bah-1546-05 and Bah-1737-06 – biomarkers for psychotic disorders
	China

	 	 	200680051802.9	 	 	 	 	Bah-1546-05 and Bah-1737-06 – biomarkers for psychotic disorders
	Europe

	 	 	2006820395	 	 	 	 	Bah-1546-05 and Bah-1737-06 – biomarkers for psychotic disorders
	Japan

	 	 	2008542840	 	 	 	 	Bah-1546-05 and Bah-1737-06 – biomarkers for psychotic disorders
	PCT

	 	 	PCT/GB2006/004433
	 	11/28/2006	 	 
	Australia

	 	 	2006318912	 	 	06/20/2008	 	 
	Canada

	 	 	2632052	 	 	05/27/2008 (National Entry)	 	 
	China

	 	 	200680051583.4	 	 	07/22/2008	 	 
	Europe

	 	 	2006808694	 	 	05/30/2008	 	 
	Japan

	 	 	2008541830	 	 	05/27/2008	 	 
	US

	 	 	12095146	 	 	10/27/2008	 	 
	GB

	 	 	GB0720548	 	10/19/2007	 	 
	GB

	 	 	GB07200545	 	10/19/2007	 	 
	GB

	 	 	GB0707001	 	4/11/2007	 	 
	PCT

	 	 	PCT/GB2004/002503
	 	06/14/2004
	 	Bah-812-01 – Biomarkers and targets-psychiatric disorders/related disorders of CNS
	Europe

	 	 	2004736765	 	 	09/01/2006
	 	Bah-812-01 – Biomarkers and targets-psychiatric disorders/related disorders of CNS
	US

	 	 	10560279	 	 	10/03/2006
	 	Bah-812-01 – Biomarkers and targets-psychiatric disorders/related disorders of CNS

 

	 	 	 	 	 	 	 	 	 
	Country	 	Application Number	 	Filing Date	 	Description
	 
	PCT

	 	PCT/GB2007/000193	 	1/22/2007	 	 
	GB

	 	GB0511302.2
	 	 	 	Bah-1360-05 – Biomarkers and targets-psychiatric disorders/related disorders of CNS
	GB

	 	GB05241110.4
	 	 	 	Bah-1510-05 – Biomarkers and targets-psychiatric disorders/related disorders of CNS
	GB

	 	GB0704515.6
	 	 	 	Bah-1901-07 – Diagnosis, Monitor, Screening for psychotic disorders
	PCT

	 	PCT/GB2008/00831
	 	 	 	Bah-1901-07 – Diagnosis, Monitor, Screening for psychotic disorders
	PCT

	 	PCT/GB2006/050140
	 	6/5/2006	 	 

	 	 	 	 	 	 	 
	Country	 	Application Number	 	Filing Date	 	Description
	 
	GB

	 	GB0724735.6
	 	12/19/2007	 	 
	GB

	 	GB0724735.6
	 	12/19/2007	 	 
	GB

	 	GB0724735.6
	 	12/19/2007	 	 
	GB

	 	GB0724735.6
	 	12/19/2007	 	 
	GB

	 	GB0724735.6
	 	12/19/2007	 	 
	GB

	 	GB0724735.6
	 	12/19/2007	 	 
	GB

	 	GB0724735.6
	 	12/19/2007	 	 
	US

	 	11/912,029
	 	6/5/2006	 	 
	GB

	 	GB701626
	 	12/01/2007
	 	Methods and Biomarkers for Diagnosing and Monitoring Psychotic Disorders
	PCT

	 	PCT/GB2008/000199
	 	1/21/2008
	 	Methods and Biomarkers for Diagnosing and Monitoring Psychotic Disorders
	EPO

	 	EP8701876.8
	 	1/21/2008
	 	Methods and Biomarkers for Diagnosing and Monitoring Psychotic Disorders
	CA

	 	Canada-2676091
	 	1/21/2008
	 	Methods and Biomarkers for Diagnosing and Monitoring Psychotic Disorders
	AU

	 	AU2008208717
	 	1/21/2008
	 	Methods and Biomarkers for Diagnosing and Monitoring Psychotic Disorders
	JP

	 	JP2009546000
	 	1/21/2008
	 	Methods and Biomarkers for Diagnosing and Monitoring Psychotic Disorders

 

SCHEDULE 2 TO CO-DEVELOPMENT AND COMMERCIALIZATION AGREEMENT

Assigned to Cambridge and Subject to Framework Agreement with Psynova

	 	 	 	 	 	 	 
	Country	 	Application Number	 	Filing Date	 	Description
	 
	Great Britian

	 	GB0818658.7
	 	10/10/2008
	 	Bah-2194-08 – Diag. and monitor. of schizophrenia and other pyschotic disorders
	Great Britian

	 	GB0818660.3
	 	10/10/2008
	 	Bah-2205-08 – Diag. and monitor. of schizophrenia and other pyschotic disorders
	 
	 	 	 	 	 	 
	Great Britian

	 	GB0915736.3
	 	9/9/2009
	 	Bah-2310-09 – Diag. and monitor of schizophrenia and other psychotic disorders
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	PSY022 (Bah-2310-09)
	 
	 	 	 	 	 	 
	 

	 	 	 	 	 	PSY024 (Bah-2318-09)
	 

	 	 	 	 	 	PSY025 (Bah-2329-09)
	 

	 	 	 	 	 	PSY026 (Bah-2338-09)
	 

	 	PSY027 (Bah-2351-09)	 	 	 	 
	PSY028 (Bah-2360-09)	 	 	 	 
	PSY029 (Bah-2361-09)exv10w9w1

Exhibit 10.9.1

RULES-BASED MEDICINE, INC.

2010 LONG TERM INCENTIVE PLAN

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 
	1.
	 	Purpose	 	 	1	 
	 
	 	 	 	 	 	 
	2.
	 	Definitions	 	 	1	 
	 
	 	 	 	 	 	 
	3.
	 	Administration.	 	 	5	 
	 
	 	(a)                        Authority of the Committee	 	 	5	 
	 
	 	(b)                        Manner of Exercise of Committee Authority	 	 	6	 
	 
	 	(c)                        Limitation of Liability	 	 	7	 
	 
	 	 	 	 	 	 
	4.
	 	Stock Subject to Plan.	 	 	7	 
	 
	 	(a)                        Overall Number of Shares Available for Delivery	 	 	7	 
	 
	 	(b)                        Application of Limitation to Grants of Awards	 	 	7	 
	 
	 	(c)                        Availability of Shares Not Issued under Awards	 	 	7	 
	 
	 	(d)                        Stock Offered	 	 	7	 
	 
	 	(e)                        Repricing and Surrender of Previous Incentive Awards	 	 	7	 
	 
	 	 	 	 	 	 
	5.
	 	Eligibility; Per Person Award Limitations	 	 	8	 
	 
	 	 	 	 	 	 
	6.
	 	Specific Terms of Awards.	 	 	8	 
	 
	 	(a)                        General	 	 	8	 
	 
	 	(b)                        Options	 	 	8	 
	 
	 	(c)                        Stock Appreciation Rights	 	 	9	 
	 
	 	(d)                        Restricted Stock	 	 	11	 
	 
	 	(e)                        Restricted Stock Units	 	 	11	 
	 
	 	(f)                        Bonus Stock and Awards in Lieu of Obligations	 	 	12	 
	 
	 	(g)                        Dividend Equivalents	 	 	12	 
	 
	 	(h)                        Other Stock-Based Awards	 	 	12	 
	 
	 	 	 	 	 	 
	7.
	 	Certain Provisions Applicable to Awards.	 	 	13	 
	 
	 	(a)                        Termination of Employment	 	 	13	 
	 
	 	(b)                        Stand-Alone, Additional, Tandem, and Substitute Awards	 	 	13	 
	 
	 	(c)                        Term of Awards	 	 	13	 
	 
	 	(d)                        Form and Timing of Payment under Awards	 	 	13	 
	 
	 	(e)                        Exemptions from Section 16(b) Liability	 	 	14	 
	 
	 	(f)                        Non-Competition Agreement	 	 	14	 
	 
	 	 	 	 	 	 
	8.
	 	Performance and Annual Incentive Awards.	 	 	14	 
	 
	 	(a)                        Performance Conditions	 	 	14	 
	 
	 	(b)                        Performance Awards Granted to Designated Covered Employees	 	 	14	 
	 
	 	(c)                        Annual Incentive Awards Granted to Designated Covered Employees	 	 	16	 
	 
	 	(d)                        Written Determinations	 	 	17	 
	 
	 	(e)  Status of Section 8(b) and Section 8(c) Awards under Section 162(m) of the Code 	 	 	18	 
	 
	 	 	 	 	 	 
	9.
	 	Subdivision or Consolidation; Recapitalization; Change in Control; Reorganization.	 	 	18	 

 

 

	 	 	 	 	 	 	 
	 
	 	(a)                       Existence of Plans and Awards	 	 	18	 
	 
	 	(b)                       Subdivision or Consolidation of Shares	 	 	18	 
	 
	 	(c)                       Corporate Recapitalization	 	 	19	 
	 
	 	(d)                       Additional Issuances	 	 	20	 
	 
	 	(e)                       Change in Control	 	 	20	 
	 
	 	(f)                       Change in Control Price	 	 	20	 
	 
	 	(g)                       Impact of Corporate Events on Awards Generally	 	 	21	 
	 
	 	 	 	 	 	 
	10.
	 	General Provisions.	 	 	21	 
	 
	 	(a)                       Transferability.	 	 	21	 
	 
	 	(b)                       Taxes	 	 	23	 
	 
	 	(c)                       Changes to this Plan and Awards	 	 	23	 
	 
	 	(d)                       Limitation on Rights Conferred under Plan	 	 	23	 
	 
	 	(e)                       Unfunded Status of Awards	 	 	23	 
	 
	 	(f)                       Nonexclusivity of this Plan	 	 	23	 
	 
	 	(g)                       Fractional Shares	 	 	24	 
	 
	 	(h)                       Severability	 	 	24	 
	 
	 	(i)                       Governing Law	 	 	24	 
	 
	 	(j)                       Conditions to Delivery of Stock	 	 	24	 
	 
	 	(k)                       Section 409A of the Code	 	 	25	 
	 
	 	(l)                       Plan Effective Date and Term	 	 	25	 

 

 

RULES-BASED MEDICINE, INC.

2010 Long Term Incentive Plan

     1. Purpose. The purpose of the Rules-Based Medicine, Inc. 2010 Long Term Incentive Plan (the
“Plan”) is to provide a means through which Rules-Based Medicine, Inc., a Delaware corporation (the
“Company”), and its Subsidiaries may attract and retain able persons as employees, directors and
consultants of the Company, and its Subsidiaries, and to provide a means whereby those persons upon
whom the responsibilities of the successful administration and management of the Company, and its
Subsidiaries, rest, and whose present and potential contributions to the welfare of the Company,
and its Subsidiaries, are of importance, can acquire and maintain stock ownership, or awards the
value of which is tied to the performance of the Company, thereby strengthening their concern for
the welfare of the Company, and its Subsidiaries, and their desire to remain employed. A further
purpose of this Plan is to provide such employees, directors and consultants with additional
incentive and reward opportunities designed to enhance the profitable growth of the Company.
Accordingly, this Plan primarily provides for the granting of Incentive Stock Options, options
which do not constitute Incentive Stock Options, Restricted Stock Awards, Restricted Stock Units,
Stock Appreciation Rights, Dividend Equivalents, Bonus Stock, Other Stock-Based Awards, Annual
Incentive Awards, Performance Awards, or any combination of the foregoing, as is best suited to the
circumstances of the particular individual as provided herein.

     2. Definitions. For purposes of this Plan, the following terms shall be defined as set forth
below, in addition to such terms defined in Section 1 hereof:

          (a) “Annual Incentive Award” means a conditional right granted to an Eligible Person under
Section 8(c) hereof to receive a cash payment, Stock or other Award, unless otherwise determined by
the Committee, after the end of a specified year.

          (b) “Award” means any Option, SAR (including Limited SAR), Restricted Stock Award, Restricted
Stock Unit, Bonus Stock, Dividend Equivalent, Other Stock-Based Award, Performance Award or Annual
Incentive Award, together with any other right or interest granted to a Participant under this
Plan.

          (c) “Beneficiary” means one or more persons, trusts or other entities which have been
designated by a Participant, in his or her most recent written beneficiary designation filed with
the Committee, to receive the benefits specified under this Plan upon such Participant’s death or
to which Awards or other rights are transferred if and to the extent permitted under Section 10(a)
hereof. If, upon a Participant’s death, there is no designated Beneficiary or surviving designated
Beneficiary, then the term Beneficiary means the persons, trusts or other entities entitled by will
or the laws of descent and distribution to receive such benefits.

          (d) “Board” means the Company’s Board of Directors.

          (e) “Bonus Stock” means Stock granted as a bonus pursuant to Section 6(f).

1

 

          (f) “Business Day” means any day other than a Saturday, a Sunday, or a day on which banking
institutions in the state of Texas are authorized or obligated by law or executive order to close.

          (g) “Change in Control” means, except as otherwise provided in an Award Agreement, the
occurrence of any of the following events:

               (i) The consummation of an agreement to acquire or a tender offer for beneficial ownership
(within the meaning of Rule 13d-3 promulgated under the Exchange Act) by any Person, of 50% or more
of either (x) the then outstanding shares of Stock (the “Outstanding Stock”) or (y) the combined
voting power of the then outstanding voting securities of the Company entitled to vote generally in
the election of directors (the “Outstanding Company Voting Securities”); provided, however, that
for purposes of this paragraph (i), the following acquisitions shall not constitute a Change in
Control: (A) any acquisition directly from the Company, (B) any acquisition by the Company, (C) any
acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company
or any entity controlled by the Company or (D) any acquisition by any entity pursuant to a
transaction that complies with clauses (A), (B) and (C) of paragraph (iii) below;

               (ii) Individuals who constitute the Incumbent Board cease for any reason to constitute at
least a majority of the Board;

               (iii) Consummation of a reorganization, merger or consolidation or sale or other disposition
of all or substantially all of the assets of the Company or an acquisition of assets of another
entity (a “Business Combination”), in each case, unless, following such Business Combination, (A)
the Outstanding Stock and Outstanding Company Voting Securities immediately prior to such Business
Combination represent or are converted into or exchanged for securities which represent or are
convertible into more than 50% of, respectively, the then outstanding shares of common stock or
common equity interests and the combined voting power of the then outstanding voting securities
entitled to vote generally in the election of directors or other governing body, as the case may
be, of the entity resulting from such Business Combination (including without limitation an entity
which as a result of such transaction owns the Company or all or substantially all of the Company’s
assets either directly or through one or more subsidiaries), (B) no Person (excluding any employee
benefit plan (or related trust) of the Company or the entity resulting from such Business
Combination) beneficially owns, directly or indirectly, 20% or more of, respectively, the then
outstanding shares of common stock or common equity interests of the entity resulting from such
Business Combination or the combined voting power of the then outstanding voting securities
entitled to vote generally in the election of directors or other governing body of such entity
except to the extent that such ownership results solely from ownership of the Company that existed
prior to the Business Combination, and (C) at least a majority of the members of the board of
directors or similar governing body of the entity resulting from such Business Combination were
members of the Incumbent Board at the time of the execution of the initial agreement, or the action
of the Board, providing for such Business Combination; or

               (iv) Approval by the stockholders of the Company of a complete liquidation or dissolution of
the Company.

2

 

For purposes of any Award that provides for a deferral of compensation under the Nonqualified
Deferred Compensation Rules, to the extent the impact of a Change in Control on such Award would
subject a Participant to additional taxes under the Nonqualified Deferred Compensation Rules, a
Change in Control for purposes of such Award will mean both a Change in Control and a “change in
the ownership or effective control of a corporation, or a change in the ownership of a substantial
portion of the assets of a corporation” within the meaning of the Nonqualified Deferred
Compensation Rules.

          (h) “Code” means the Internal Revenue Code of 1986, as amended from time to time, including
regulations thereunder and successor provisions and regulations thereto.

          (i) “Committee” means a committee of two or more directors designated by the Board to
administer this Plan; provided, however, that, unless otherwise determined by the Board, the
Committee shall consist solely of two or more directors, each of whom shall be a Qualified Member
(except to the extent administration of this Plan by “outside directors” is not then required in
order to qualify for tax deductibility under section 162(m) of the Code).

          (j) “Covered Employee” means an Eligible Person who is a Covered Employee as specified in
Section 8(e) of this Plan.

          (k) “Dividend Equivalent” means a right, granted to an Eligible Person under Section 6(g), to
receive cash, Stock, other Awards or other property equal in value to dividends paid with respect
to a specified number of shares of Stock, or other periodic payments.

          (l) “Effective Date” means March 12, 2010.

          (m) “Eligible Person” means all officers and employees of the Company or of any of its
Subsidiaries, and other persons who provide services to the Company or any of its Subsidiaries,
including directors of the Company. An employee on leave of absence may be considered as still in
the employ of the Company or any of its Subsidiaries for purposes of eligibility for participation
in this Plan.

          (n) “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time,
including rules thereunder and successor provisions and rules thereto.

          (o) “Fair Market Value” means, as of any specified date, (i) if the Stock is listed on a
national securities exchange, the closing sales price of the Stock, as reported on the stock
exchange composite tape on that date (or if no sales occur on that date, on the last preceding date
on which such sales of the Stock are so reported); (ii) if the Stock is not traded on a national
securities exchange but is traded over the counter at the time a determination of its fair market
value is required to be made under the Plan, the average between the reported high and low bid and
asked prices of Stock on the most recent date on which Stock was publicly traded; (iii) in the
event Stock is not publicly traded at the time a determination of its value is required to be made
under the Plan, the amount determined by the Committee in its discretion in such manner as it deems
appropriate, taking into account all factors the Committee deems appropriate including, without
limitation, the Nonqualified Deferred Compensation Rules; or (iv) on the date

3

 

of a Qualifying Public Offering of Stock, the offering price under such Qualifying Public
Offering.

          (p) “Incentive Stock Option” or “ISO” means any Option intended to be and designated as an
incentive stock option within the meaning of section 422 of the Code or any successor provision
thereto.

          (q) “Incumbent Board” means the portion of the Board constituted of the individuals who are
members of the Board as of the Effective Date, and any individual who becomes a director of the
Company after the Effective Date and whose election or appointment by the Board or nomination for
election by the Company’s stockholders was approved by a vote of at least a majority of the
directors then comprising the Incumbent Board, but excluding, for this purpose, any such individual
whose initial assumption of office occurs as a result of an actual or threatened election contest
with respect to the election or removal of directors or other actual or threatened solicitation of
proxies or consents by or on behalf of a Person other than the Incumbent Board.

          (r) “Nonqualified Deferred Compensation Rules” means the limitations or requirements of
section 409A of the Code and the guidance and regulations promulgated thereunder.

          (s) “Option” means a right, granted to an Eligible Person under Section 6(b) hereof, to
purchase Stock or other Awards at a specified price during specified time periods.

          (t) “Other Stock-Based Awards” means Awards granted to an Eligible Person under Section 6(h)
hereof.

          (u) “Participant” means a person who has been granted an Award under this Plan which remains
outstanding, including a person who is no longer an Eligible Person.

          (v) “Performance Award” means a right, granted to an Eligible Person under Section 8 hereof,
to receive Awards based upon performance criteria specified by the Committee.

          (w) “Person” means any person or entity of any nature whatsoever, specifically including an
individual, a firm, a company, a corporation, a partnership, a limited liability company, a trust
or other entity; a Person, together with that Person’s Affiliates and Associates (as those terms
are defined in Rule 12b-2 under the Exchange Act, provided that “registrant” as used in Rule 12b-2
shall mean the Company), and any Persons acting as a partnership, limited partnership, joint
venture, association, syndicate or other group (whether or not formally organized), or otherwise
acting jointly or in concert or in a coordinated or consciously parallel manner (whether or not
pursuant to any express agreement), for the purpose of acquiring, holding, voting or disposing of
securities of the Company with such Person, shall be deemed a single “Person.”

4

 

          (x) “Qualifying Public Offering” means a firm commitment underwritten public offering of Stock
for cash where the shares of Stock registered under the Securities Act are listed on a national
securities exchange.

          (y) “Qualified Member” means a member of the Committee who is a “nonemployee director” within
the meaning of Rule 16b-3 and an “outside director” within the meaning of Treasury Regulation
1.162-27 under section 162(m) of the Code.

          (z) “Restricted Stock” means Stock granted to an Eligible Person under Section 6(d) hereof,
that is subject to certain restrictions and to a risk of forfeiture.

          (aa) “Restricted Stock Unit” means a right, granted to an Eligible Person under Section 6(e)
hereof, to receive Stock, cash or a combination thereof at the end of a specified deferral period.

          (bb) “Rule 16b-3” means Rule 16b-3 promulgated by the Securities and Exchange Commission under
section 16 of the Exchange Act, as from time to time in effect and applicable to this Plan and
Participants.

          (cc) “Securities Act” means the Securities Act of 1933 and the rules and regulations
promulgated thereunder, or any successor law, as it may be amended from time to time.

          (dd) “Stock” means the Company’s Common Stock, par value $0.001 per share, and such other
securities as may be substituted (or resubstituted) for Stock pursuant to Section 9.

          (ee) “Stock Appreciation Rights” or “SAR” means a right granted to an Eligible Person under
Section 6(c) hereof.

          (ff) “Subsidiary” means, with respect to the Company, any corporation or other entity of which
a majority of the voting power of the voting equity securities or equity interest is owned,
directly or indirectly, by the Company.

     3. Administration.

          (a) Authority of the Committee. This Plan shall be administered by the Committee
except to the extent the Board elects to administer this Plan, in which case references herein to
the “Committee” shall be deemed to include references to the “Board.” Subject to the express
provisions of the Plan and Rule 16b-3, the Committee shall have the authority, in its sole and
absolute discretion, to (i) adopt, amend, and rescind administrative and interpretive rules and
regulations relating to the Plan; (ii) determine the Eligible Persons to whom, and the time or
times at which, Awards shall be granted; (iii) determine the amount of cash and/or the number of
shares of Stock, as applicable Stock Appreciation Rights, Restricted Stock Units, Restricted Stock
Awards, Dividend Equivalents, Bonus Stock, Other Stock-Based Awards, Annual Incentive Awards,
Performance Awards, or any combination thereof, that shall be the subject of each Award; (iv)
determine the terms and provisions of each Award agreement (which need not

5

 

be identical), including provisions defining or otherwise relating to (A) the term and the
period or periods and extent of exercisability of the Options, (B) the extent to which the
transferability of shares of Stock issued or transferred pursuant to any Award is restricted, (C)
except as otherwise provided herein, the effect of termination of employment, or the service
relationship with the Company, of a Participant on the Award, and (D) the effect of approved leaves
of absence (consistent with any applicable regulations of the Internal Revenue Service); (v)
accelerate the time of exercisability of any Award that has been granted; (vi) construe the
respective Award agreements and the Plan; (vii) make determinations of the Fair Market Value of the
Stock pursuant to the Plan; (viii) delegate its duties under the Plan to such agents as it may
appoint from time to time, provided that the Committee may not delegate its duties where such
delegation would violate state corporate law, or with respect to making Awards to, or otherwise
with respect to Awards granted to, Eligible Persons who are subject to section 16(b) of the
Exchange Act or who are Covered Employees receiving Awards that are intended to constitute
“performance-based compensation” within the meaning of section 162(m) of the Code; (ix) subject to
Section 10(c), terminate, modify or amend the Plan; and (x) make all other determinations, perform
all other acts, and exercise all other powers and authority necessary or advisable for
administering the Plan, including the delegation of those ministerial acts and responsibilities as
the Committee deems appropriate. Subject to Rule 16b-3 and section 162(m) of the Code, the
Committee may correct any defect, supply any omission, or reconcile any inconsistency in the Plan,
in any Award, or in any Award agreement in the manner and to the extent it deems necessary or
desirable to carry the Plan into effect, and the Committee shall be the sole and final judge of
that necessity or desirability. The determinations of the Committee on the matters referred to in
this Section 3(a) shall be final and conclusive.

          (b) Manner of Exercise of Committee Authority. At any time that a member of the
Committee is not a Qualified Member, any action of the Committee relating to an Award granted or to
be granted to an Eligible Person who is then subject to section 16 of the Exchange Act in respect
of the Company, or relating to an Award intended by the Committee to qualify as “performance-based
compensation” within the meaning of section 162(m) of the Code and regulations thereunder, may be
taken either (i) by a subcommittee, designated by the Committee, composed solely of two or more
Qualified Members, or (ii) by the Committee but with each such member who is not a Qualified Member
abstaining or recusing himself or herself from such action; provided, however, that, upon such
abstention or recusal, the Committee remains composed solely of two or more Qualified Members.
Such action, authorized by such a subcommittee or by the Committee upon the abstention or recusal
of such non-Qualified Member(s), shall be the action of the Committee for purposes of this Plan.
Any action of the Committee shall be final, conclusive and binding on all Persons, including the
Company, its Subsidiaries, stockholders, Participants, Beneficiaries, and transferees under Section
10(a) hereof or other persons claiming rights from or through a Participant. The express grant of
any specific power to the Committee, and the taking of any action by the Committee, shall not be
construed as limiting any power or authority of the Committee. The Committee may delegate to
officers or managers of the Company or any of its Subsidiaries, or committees thereof, the
authority, subject to such terms as the Committee shall determine, to perform such functions,
including administrative functions, as the Committee may determine, to the extent that such
delegation will not result in the loss of an exemption under Rule 16b-3 for Awards granted to
Participants subject to section 16 of the Exchange Act in respect of the Company and will not cause
Awards

6

 

intended to qualify as “performance-based compensation” under section 162(m) of the Code to
fail to so qualify. The Committee may appoint agents to assist it in administering the Plan.

          (c) Limitation of Liability. The Committee and each member thereof shall be entitled
to, in good faith, rely or act upon any report or other information furnished to him or her by any
officer or employee of the Company or any of its Subsidiaries, the Company’s legal counsel,
independent auditors, consultants or any other agents assisting in the administration of this Plan.
Members of the Committee and any officer or employee of the Company or any of its Subsidiaries
acting at the direction or on behalf of the Committee shall not be personally liable for any action
or determination taken or made in good faith with respect to this Plan, and shall, to the fullest
extent permitted by law, be indemnified and held harmless by the Company with respect to any such
action or determination.

     4. Stock Subject to Plan.

          (a) Overall Number of Shares Available for Delivery. Subject to adjustment in a
manner consistent with any adjustment made pursuant to Section 9, the total number of shares of
Stock reserved and available for issuance in connection with Awards under this Plan shall not
exceed 2,200,000 shares.

          (b) Application of Limitation to Grants of Awards. Subject to Section 4(e), no Award
may be granted if the number of shares of Stock to be delivered in connection with such Award
exceeds the number of shares of Stock remaining available under this Plan minus the number of
shares of Stock issuable in settlement of or relating to then-outstanding Awards. The Committee
may adopt reasonable counting procedures to ensure appropriate counting, avoid double counting (as,
for example, in the case of tandem or substitute awards) and make adjustments if the number of
shares of Stock actually delivered differs from the number of shares previously counted in
connection with an Award.

          (c) Availability of Shares Not Issued under Awards. Shares of Stock subject to an
Award under this Plan that expire or are canceled, forfeited, exchanged, settled in cash or
otherwise terminated, including (i) shares forfeited with respect to Restricted Stock, (ii) the
number of shares withheld in payment of any exercise or purchase price of an Award or taxes
relating to Awards, and (iii) the number of shares surrendered in payment of any exercise or
purchase price of an Award or taxes relating to any Award, will again be available for Awards under
this Plan, except that if any such shares could not again be available for Awards to a particular
Participant under any applicable law or regulation, such shares shall be available exclusively for
Awards to Participants who are not subject to such limitation.

          (d) Stock Offered. The shares to be delivered under the Plan shall be made available
from (i) authorized but unissued shares of Stock, (ii) Stock held in the treasury of the Company,
or (iii) previously issued shares of Stock reacquired by the Company, including shares purchased on
the open market.

          (e) Repricing and Surrender of Previous Incentive Awards. The Committee may, in its
absolute discretion, grant Awards (or cash payments) to Eligible Persons on the condition that such
Eligible Persons surrender to the Committee for cancellation such other

7

 

Awards (including, without limitation, Awards with higher Exercise Prices) as the Committee
directs. Awards granted on the condition precedent of surrender of outstanding Awards shall not
count against the limits set forth in Section 4(a) until such time as such previous Awards are
surrendered and cancelled.

     5. Eligibility; Per Person Award Limitations. Awards may be granted under this Plan only to
Persons who are Eligible Persons at the time of grant thereof or in connection with the severance
or retirement of Eligible Persons. In each calendar year, during any part of which this Plan is in
effect, a Covered Employee may not be granted (a) Awards (other than Awards designated to be paid
only in cash or the settlement of which is not based on a number of shares of Stock) relating to
more than 2,200,000 shares of Stock, subject to adjustment in a manner consistent with any
adjustment made pursuant to Section 9, and (b) Awards designated to be paid only in cash, or the
settlement of which is not based on a number of shares of Stock, having a value determined on the
date of grant in excess of $2,000,000.

     6. Specific Terms of Awards.

          (a) General. Awards may be granted on the terms and conditions set forth in this
Section 6. In addition, the Committee may impose on any Award or the exercise thereof, at the date
of grant or thereafter (subject to Section 10(c)), such additional terms and conditions, not
inconsistent with the provisions of this Plan, as the Committee shall determine, including terms
requiring forfeiture of Awards in the event of termination of employment by the Participant, or
termination of the Participant’s service relationship with the Company, and terms permitting a
Participant to make elections relating to his or her Award. The Committee shall retain full power
and discretion to accelerate, waive or modify, at any time, any term or condition of an Award that
is not mandatory under this Plan; provided, however, that the Committee shall not have any
discretion to accelerate, waive or modify any term or condition of an Award that is intended to
qualify as “performance-based compensation” for purposes of section 162(m) of the Code if such
discretion would cause the Award to not so qualify or to accelerate the terms of payment of any
Award that provides for a deferral of compensation under the Nonqualified Deferred Compensation
Rules if such acceleration would subject a Participant to additional taxes under the Nonqualified
Deferred Compensation Rules.

          (b) Options. The Committee is authorized to grant Options to Eligible Persons on the
following terms and conditions:

               (i) Exercise Price. Each Option agreement shall state the exercise price per share of
Stock (the “Exercise Price”); provided, however, that the Exercise Price per share
of Stock subject to an Option that is intended to be an ISO or is not intended to constitute a
deferral of compensation pursuant to the Nonqualified Deferred Compensation Rules shall not be less
than the greater of (A) the par value per share of the Stock or (B) 100% of the Fair Market Value
per share of the Stock as of the date of grant of the Option (or, with respect to any ISO, in the
case of an individual who owns stock possessing more than 10 percent of the total combined voting
power of all classes of stock of the Company or its parent or any subsidiary, 110% of the Fair
Market Value per share of the Stock on the date of grant).

8

 

               (ii) Time and Method of Exercise. The Committee shall determine the time or times at
which or the circumstances under which an Option may be exercised in whole or in part (including
based on achievement of performance goals and/or future service requirements), the methods by which
such Exercise Price may be paid or deemed to be paid, the form of such payment, including without
limitation cash, Stock, other Awards or awards granted under other plans of the Company or any
Subsidiary, or other property (including notes or other contractual obligations of Participants to
make payment on a deferred basis), and the methods by or forms in which Stock will be delivered or
deemed to be delivered to Participants, including, but not limited to, the delivery of Restricted
Stock subject to Section 6(d). In the case of an exercise whereby the Exercise Price is paid with
Stock, such Stock shall be valued as of the date of exercise.

               (iii) ISOs. The maximum number of shares of Stock that may be issued under the Plan
pursuant to the exercise of ISOs shall be 2,200,000 shares. The terms of any ISO granted under
this Plan shall comply in all respects with the provisions of section 422 of the Code. Except as
otherwise provided in Section 9, no term of this Plan relating to ISOs (including any SAR in tandem
therewith) shall be interpreted, amended or altered, nor shall any discretion or authority granted
under this Plan be exercised, so as to disqualify either this Plan or any ISO under section 422 of
the Code, unless the Participant has first requested the change that will result in such
disqualification. ISOs shall not be granted more than ten years after the earlier of the adoption
of this Plan or the approval of this Plan by the Company’s stockholders. Notwithstanding the
foregoing, the Fair Market Value of shares of Stock subject to an ISO and the aggregate Fair Market
Value of shares of stock of any parent or subsidiary corporation (within the meaning of sections
424(e) and (f) of the Code) subject to any other ISO (within the meaning of section 422 of the
Code) of the Company or a parent or subsidiary corporation (within the meaning of sections 424(e)
and (f) of the Code) that first becomes purchasable by a Participant in any calendar year may not
(with respect to that Participant) exceed $100,000, or such other amount as may be prescribed under
section 422 of the Code or applicable regulations or rulings from time to time. As used in the
previous sentence, Fair Market Value shall be determined as of the date the ISOs are granted.
Failure to comply with this provision shall not impair the enforceability or exercisability of any
Option, but shall cause the excess amount of shares to be reclassified in accordance with the Code.

          (c) Stock Appreciation Rights. The Committee is authorized to grant SARs to Eligible
Persons on the following terms and conditions:

               (i) Right to Payment. An SAR shall confer on the Participant to whom it is granted a
right to receive, upon exercise thereof, the excess of (A) the Fair Market Value of one share of
Stock on the date of exercise over (B) the grant price of the SAR as determined by the Committee.

               (ii) Rights Related to Options. An SAR granted pursuant to an Option shall entitle a
Participant, upon exercise, to surrender that Option or any portion thereof, to the extent
unexercised, and to receive payment of an amount computed pursuant to Section 6(c)(ii)(B). That
Option shall then cease to be exercisable to the extent surrendered. SARs granted in connection
with an Option shall be subject to the terms of the Award agreement

9

 

governing the Option, which shall comply with the following provisions in addition to those
applicable to Options:

                    (A) An SAR granted in connection with an Option shall be exercisable only at such time or
times and only to the extent that the related Option is exercisable and shall not be transferable
except to the extent that the related Option is transferable.

                    (B) Upon the exercise of an SAR related to an Option, a Participant shall be entitled to
receive payment from the Company of an amount determined by multiplying:

                         (1) the difference obtained by subtracting the Exercise Price with respect to a share of Stock
specified in the related Option from the Fair Market Value of a share of Stock on the date of
exercise of the SAR, by

                         (2) the number of shares as to which that SAR has been exercised.

               (iii) Right Without Option. An SAR granted independent of an Option shall be
exercisable as determined by the Committee and set forth in the Award agreement governing the SAR,
which Award agreement shall comply with the following provisions:

                    (A) Each Award agreement shall state the total number of shares of Stock to which the SAR
relates.

                    (B) Each Award agreement shall state the time or periods in which the right to exercise the
SAR or a portion thereof shall vest and the number of shares of Stock for which the right to
exercise the SAR shall vest at each such time or period.

                    (C) Each Award agreement shall state the date at which the SARs shall expire if not previously
exercised.

                    (D) Each SAR shall entitle a Participant, upon exercise thereof, to receive payment of an
amount determined by multiplying:

                         (1) the difference obtained by subtracting the Fair Market Value of a share of Stock on the
date of grant of the SAR from the Fair Market Value of a share of Stock on the date of exercise of
that SAR, by

                         (2) the number of shares as to which the SAR has been exercised.

               (iv) Terms. Except as otherwise provided herein, the Committee shall determine at the
date of grant or thereafter, the time or times at which and the circumstances under which an SAR
may be exercised in whole or in part (including based on achievement of performance goals and/or
future service requirements), the method of exercise, method of settlement, form of consideration
payable in settlement, method by or forms in which Stock will be delivered or deemed to be
delivered to Participants, whether or not an SAR shall be in tandem

10

 

or in combination with any other Award, and any other terms and conditions of any SAR. SARs
may be either freestanding or in tandem with other Awards.

          (d) Restricted Stock. The Committee is authorized to grant Restricted Stock to
Eligible Persons on the following terms and conditions:

               (i) Grant and Restrictions. Restricted Stock shall be subject to such restrictions on
transferability, risk of forfeiture and other restrictions, if any, as the Committee may impose,
which restrictions may lapse separately or in combination at such times, under such circumstances
(including based on achievement of performance goals and/or future service requirements), in such
installments or otherwise, as the Committee may determine at the date of grant or thereafter.
During the restricted period applicable to the Restricted Stock, the Restricted Stock may not be
sold, transferred, pledged, hypothecated, margined or otherwise encumbered by the Participant.

               (ii) Certificates for Stock. Restricted Stock granted under this Plan may be
evidenced in such manner as the Committee shall determine. If certificates representing Restricted
Stock are registered in the name of the Participant, the Committee may require that such
certificates bear an appropriate legend referring to the terms, conditions and restrictions
applicable to such Restricted Stock, that the Company retain physical possession of the
certificates, and that the Participant deliver a stock power to the Company, endorsed in blank,
relating to the Restricted Stock.

               (iii) Dividends and Splits. As a condition to the grant of an Award of Restricted
Stock, the Committee may require or permit a Participant to elect that any cash dividends paid on a
share of Restricted Stock be automatically reinvested in additional shares of Restricted Stock,
applied to the purchase of additional Awards under this Plan, or deferred without interest to the
date of vesting of the associated Award of Restricted Stock; provided, that, to the extent
applicable, any such election shall comply with the Nonqualified Deferred Compensation Rules.
Unless otherwise determined by the Committee, Stock distributed in connection with a Stock split or
Stock dividend, and other property (other than cash) distributed as a dividend, shall be subject to
restrictions and a risk of forfeiture to the same extent as the Restricted Stock with respect to
which such Stock or other property has been distributed.

          (e) Restricted Stock Units. The Committee is authorized to grant Restricted Stock
Units, which are rights to receive Stock or cash (or a combination thereof) at the end of a
specified deferral period (which may or may not be coterminous with the vesting schedule of the
Award), to Eligible Persons, subject to the following terms and conditions:

               (i) Award and Restrictions. Settlement of an Award of Restricted Stock Units shall
occur upon expiration of the deferral period specified for such Restricted Stock Unit by the
Committee (or, if permitted by the Committee, as elected by the Participant). In addition,
Restricted Stock Units shall be subject to such restrictions (which may include a risk of
forfeiture) as the Committee may impose, if any, which restrictions may lapse at the expiration of
the deferral period or at earlier specified times (including based on achievement of performance
goals and/or future service requirements), separately or in combination, in installments or
otherwise, as the Committee may determine. Restricted Stock Units shall be

11

 

satisfied by the delivery of cash or Stock in the amount equal to the Fair Market Value of the
specified number of shares of Stock covered by the Restricted Stock Units, or a combination
thereof, as determined by the Committee at the date of grant or thereafter.

               (ii) Dividend Equivalents. Unless otherwise determined by the Committee at date of
grant, Dividend Equivalents on the specified number of shares of Stock covered by an Award of
Restricted Stock Units shall be either (A) paid with respect to such Restricted Stock Units on the
dividend payment date in cash or in shares of unrestricted Stock having a Fair Market Value equal
to the amount of such dividends, or (B) deferred with respect to such Restricted Stock Units and
the amount or value thereof automatically deemed reinvested in additional Restricted Stock Units,
other Awards or other investment vehicles, as the Committee shall determine or permit the
Participant to elect.

          (f) Bonus Stock and Awards in Lieu of Obligations. The Committee is authorized to
grant Bonus Stock, or to grant Stock or other Awards in lieu of obligations to pay cash or deliver
other property under this Plan or under other plans or compensatory arrangements; provided, that,
in the case of Participants subject to section 16 of the Exchange Act, the amount of such grants
remains within the discretion of the Committee to the extent necessary to ensure that acquisitions
of Stock or other Awards are exempt from liability under section 16(b) of the Exchange Act. Stock
or Awards granted hereunder shall be subject to such other terms as shall be determined by the
Committee. In the case of any grant of Stock to an officer of the Company or any of its
Subsidiaries in lieu of salary or other cash compensation, the number of shares granted in place of
such compensation shall be reasonable, as determined by the Committee.

          (g) Dividend Equivalents. The Committee is authorized to grant Dividend Equivalents
to an Eligible Person, entitling the Participant to receive cash, Stock, other Awards, or other
property equal in value to dividends paid with respect to a specified number of shares of Stock, or
other periodic payments. Dividend Equivalents may be awarded on a free-standing basis or in
connection with another Award. The Committee may provide that Dividend Equivalents shall be paid
or distributed when accrued or shall be deemed to have been reinvested in additional Stock, Awards,
or other investment vehicles, and subject to such restrictions on transferability and risks of
forfeiture, as the Committee may specify.

          (h) Other Stock-Based Awards. The Committee is authorized, subject to limitations
under applicable law, to grant to Eligible Persons such other Awards that may be denominated or
payable in, valued in whole or in part by reference to, or otherwise based on, or related to,
Stock, as deemed by the Committee to be consistent with the purposes of this Plan, including
without limitation convertible or exchangeable debt securities, other rights convertible or
exchangeable into Stock, purchase rights for Stock, Awards with value and payment contingent upon
performance of the Company or any other factors designated by the Committee, and Awards valued by
reference to the book value of Stock or the value of securities of, or the performance of,
specified Subsidiaries of the Company. The Committee shall determine the terms and conditions of
such Other Stock-Based Awards. Stock delivered pursuant to an Award in the nature of a purchase
right granted under this Section 6(h) shall be purchased for such consideration, paid for at such
times, by such methods, and in such forms, including, without limitation, cash, Stock, other
Awards, or other property, as the Committee shall determine. Cash

12

 

awards, as an element of or supplement to any other Award under this Plan, may also be granted
pursuant to this Section 6(h).

     7. Certain Provisions Applicable to Awards.

          (a) Termination of Employment. Except as provided herein, the treatment of an Award
upon a termination of employment or any other service relationship by and between a Participant and
the Company or any Subsidiary shall be specified in the agreement controlling such Award.

          (b) Stand-Alone, Additional, Tandem, and Substitute Awards. Awards granted under this
Plan may, in the discretion of the Committee, be granted either alone or in addition to, in tandem
with, or in substitution or exchange for, any other Award or any award granted under another plan
of the Company or any of its Subsidiaries, or of any business entity to be acquired by the Company
or any of its Subsidiaries, or any other right of an Eligible Person to receive payment from the
Company or any of its Subsidiaries. Such additional, tandem and substitute or exchange Awards may
be granted at any time. If an Award is granted in substitution or exchange for another Award, the
Committee shall require the surrender of such other Award in consideration for the grant of the new
Award. Awards under this Plan may be granted in lieu of cash compensation, including in lieu of
cash amounts payable under other plans of the Company or any of its Subsidiaries, in which the
value of Stock subject to the Award is equivalent in value to the cash compensation, or in which
the exercise price, grant price or purchase price of the Award in the nature of a right that may be
exercised is equal to the Fair Market Value of the underlying Stock minus the value of the cash
compensation surrendered. Awards granted pursuant to the preceding sentence shall be designed,
awarded and settled in a manner that does not result in additional taxes under the Nonqualified
Deferred Compensation Rules.

          (c) Term of Awards. Except as specified herein, the term of each Award shall be for
such period as may be determined by the Committee; provided, that in no event shall the term of any
Option or SAR exceed a period of ten years (or such shorter term as may be required in respect of
an ISO under section 422 of the Code).

          (d) Form and Timing of Payment under Awards. Subject to the terms of this Plan and
any applicable Award agreement, payments to be made by the Company or any of its Subsidiaries upon
the exercise of an Option or other Award or settlement of an Award may be made in such forms as the
Committee shall determine, including without limitation cash, Stock, other Awards or other
property, and may be made in a single payment or transfer, in installments, or on a deferred basis;
provided, however, that any such deferred payment will be set forth in the agreement evidencing
such Award and/or otherwise made in a manner that will not result in additional taxes under the
Nonqualified Deferred Compensation Rules. Except as otherwise provided herein, the settlement of
any Award may be accelerated, and cash paid in lieu of Stock in connection with such settlement, in
the discretion of the Committee or upon occurrence of one or more specified events (in addition to
a Change in Control). Installment or deferred payments may be required by the Committee (subject
to Section 10(c) of this Plan, including the consent provisions thereof in the case of any deferral
of an outstanding Award not provided for in the original Award agreement) or permitted at the
election of the Participant on

13

 

terms and conditions established by the Committee and in compliance with the Nonqualified
Deferred Compensation Rules. Payments may include, without limitation, provisions for the payment
or crediting of reasonable interest on installment or deferred payments or the grant or crediting
of Dividend Equivalents or other amounts in respect of installment or deferred payments denominated
in Stock. Any deferral shall only be allowed as is provided in a separate deferred compensation
plan adopted by the Company and shall be made pursuant to the Nonqualified Deferred Compensation
Rules. This Plan shall not constitute an “employee benefit plan” for purposes of section 3(3) of
the Employee Retirement Income Security Act of 1974, as amended.

          (e) Exemptions from Section 16(b) Liability. It is the intent of the Company that the
grant of any Awards to or other transaction by a Participant who is subject to section 16 of the
Exchange Act shall be exempt from such section pursuant to an applicable exemption (except for
transactions acknowledged in writing to be non-exempt by such Participant). Accordingly, if any
provision of this Plan or any Award agreement does not comply with the requirements of Rule 16b-3
as then applicable to any such transaction, such provision shall be construed or deemed amended to
the extent necessary to conform to the applicable requirements of Rule 16b-3 so that such
Participant shall avoid liability under section 16(b) of the Exchange Act.

          (f) Non-Competition Agreement. Each Participant to whom an Award is granted under
this Plan may be required to agree in writing as a condition to the granting of such Award not to
engage in conduct in competition with the Company or any of its Subsidiaries for a period after the
termination of such Participant’s employment with the Company and its Subsidiaries as determined by
the Committee.

     8. Performance and Annual Incentive Awards.

          (a) Performance Conditions. The right of an Eligible Person to receive a grant, and
the right of a Participant to exercise or receive a settlement of any Award, and the timing
thereof, may be subject to such performance conditions as may be specified by the Committee. The
Committee may use such business criteria and other measures of performance as it may deem
appropriate in establishing any performance conditions, and may exercise its discretion to reduce
or increase the amounts payable under any Award subject to performance conditions, except as
limited under Sections 8(b) and 8(c) hereof in the case of a Performance Award or Annual Incentive
Award intended to qualify under section 162(m) of the Code.

          (b) Performance Awards Granted to Designated Covered Employees. If the Committee
determines that a Performance Award to be granted to an Eligible Person who is designated by the
Committee as likely to be a Covered Employee should qualify as “performance-based compensation” for
purposes of section 162(m) of the Code, the grant, exercise and/or settlement of such Performance
Award may be contingent upon achievement of preestablished performance goals and other terms set
forth in this Section 8(b).

               (i) Performance Goals Generally. The performance goals for such Performance Awards
shall consist of one or more business criteria or individual performance criteria and a targeted
level or levels of performance with respect to each of such criteria, as

14

 

specified by the Committee consistent with this Section 8(b). Performance goals shall be
objective and shall otherwise meet the requirements of section 162(m) of the Code and regulations
thereunder (including Treasury Regulation § 1.162-27 and successor regulations thereto), including
the requirement that the level or levels of performance targeted by the Committee result in the
achievement of performance goals being “substantially uncertain” at the time the Committee actually
establishes the performance goal or goals. The Committee may determine that such Performance
Awards shall be granted, exercised, and/or settled upon achievement of any one performance goal or
that two or more of the performance goals must be achieved as a condition to grant, exercise,
and/or settlement of such Performance Awards. Performance goals may differ for Performance Awards
granted to any one Participant or to different Participants. In establishing or adjusting a
performance goal, the Committee may exclude the impact of any of the following events or
occurrences which the Committee determines should appropriately be excluded: (a) any amounts
accrued by the Company or its Subsidiaries pursuant to management bonus plans or cash profit
sharing plans and related employer payroll taxes for the fiscal year; (b) any discretionary or
matching contributions made to the savings and deferred profit-sharing plan or deferred
compensation plan for the fiscal year; (c) asset write-downs; (d) litigation, claims, judgments or
settlements; (e) the effect of changes in tax law or other such laws or regulations affecting
reported results; (f) accruals for reorganization and restructuring programs; (g) any
extraordinary, unusual or nonrecurring items as described in the Accounting Standards Codification
Topic 225, as the same may be amended or superseded from time to time; (h) any change in accounting
principle as defined in the Accounting Standards Codification Topic 250, as the same may be amended
or superseded from time to time; (i) any loss from a discontinued operation as described in the
Accounting Standards Codification Topic 360, as the same may be amended or superseded from time to
time; (j) goodwill impairment charges; (k) operating results for any business acquired during the
Plan Year; (l) third party expenses associated with any acquisition by the Company or any
Subsidiary; and (m) any other extraordinary events or occurrences identified by the Committee.

               (ii) Business and Individual Performance Criteria.

                    (A) Business Criteria. One or more of the following business criteria for the
Company, on a consolidated basis, and/or for specified Subsidiaries or business or geographical
units of the Company (except with respect to the total stockholder return and earnings per share
criteria), shall be used by the Committee in establishing performance goals for such Performance
Awards: (1) earnings per share; (2) increase in revenues; (3) increase in cash flow; (4) increase
in cash flow from operations; (5) increase in cash flow return; (6) return on net assets; (7)
return on assets; (8) return on investment; (9) return on capital; (10) return on equity; (11)
economic value added; (12) operating margin; (13) contribution margin; (14) net income; (15) net
income per share; (16) pretax earnings; (17) pretax earnings before interest, depreciation and
amortization; (18) pretax operating earnings after interest expense and before incentives, service
fees and extraordinary or special items; (19) total stockholder return; (20) debt reduction; (21)
market share; (22) change in the Fair Market Value of the Stock; (23) operating income; (24)
operational metrics; and (25) any of the above goals determined on an absolute or relative basis or
as compared to the performance of a published or special index deemed applicable by the Committee,
including, but not limited to, the Standard & Poor’s 500 Stock Index or a group of comparable
companies. One or more of the foregoing business criteria shall also be

15

 

exclusively used in establishing performance goals for Annual Incentive Awards granted to a
Covered Employee under Section 8(c) hereof that are intended to qualify as “performance-based
compensation” under section 162(m) of the Code.

                    (B) Individual Performance Criteria. The grant, exercise and/or settlement of
Performance Awards may also be contingent upon individual performance goals established by the
Committee including individual business objectives and criteria specific to an individual’s
position and responsibility with the Company or its Subsidiaries. If required for compliance with
section 162(m) of the Code, such criteria shall be approved by the stockholders of the Company.

               (iii) Performance Period; Timing for Establishing Performance Goals. Achievement of
performance goals in respect of such Performance Awards shall be measured over a performance period
of up to ten years, as specified by the Committee. Performance goals shall be established not
later than 90 days after the beginning of any performance period applicable to such Performance
Awards, or at such other date as may be required or permitted for “performance-based compensation”
under section 162(m) of the Code.

               (iv) Performance Award Pool. The Committee may establish a Performance Award pool,
which shall be an unfunded pool, for purposes of measuring performance of the Company in connection
with Performance Awards. The amount of such Performance Award pool shall be based upon the
achievement of a performance goal or goals based on one or more of the criteria set forth in
Section 8(b)(ii) hereof during the given performance period, as specified by the Committee in
accordance with Section 8(b)(iii) hereof. The Committee may specify the amount of the Performance
Award pool as a percentage of any such criteria, a percentage thereof in excess of a threshold
amount, or as another amount which need not bear a strictly mathematical relationship to such
criteria.

               (v) Settlement of Performance Awards; Other Terms. After the end of each performance
period, the Committee shall determine the amount, if any, of (A) the Performance Award pool and the
maximum amount of the potential Performance Award payable to each Participant in the Performance
Award pool, or (B) the amount of the potential Performance Award otherwise payable to each
Participant. Settlement of such Performance Awards shall be in cash, Stock, other Awards or other
property, in the discretion of the Committee. The Committee may, in its discretion, reduce the
amount of a settlement otherwise to be made in connection with such Performance Awards, or adjust
the amount of a settlement otherwise to be made in connection with such Performance Awards to
reflect the events or occurrences set forth in Section 8(b)(i), but may not exercise discretion to
increase any such amount payable to a Covered Employee in respect of a Performance Award subject to
this Section 8(b). The Committee shall specify the circumstances in which such Performance Awards
shall be paid or forfeited in the event of termination of employment by the Participant prior to
the end of a performance period or settlement of Performance Awards.

          (c) Annual Incentive Awards Granted to Designated Covered Employees. If the Committee
determines that an Annual Incentive Award to be granted to an Eligible Person who is designated by
the Committee as likely to be a Covered Employee should qualify as “performance-based compensation”
for purposes of section 162(m) of the Code, the grant,

16

 

exercise and/or settlement of such Annual Incentive Award shall be contingent upon achievement
of preestablished performance goals and other terms set forth in this Section 8(c).

               (i) Potential Annual Incentive Awards. Not later than the end of the 90th day of each
applicable year, or at such other date as may be required or permitted in the case of Awards
intended to be “performance-based compensation” under section 162(m) of the Code, the Committee
shall determine the Eligible Persons who will potentially receive Annual Incentive Awards, and the
amounts potentially payable thereunder for that fiscal year, either out of an Annual Incentive
Award pool established by such date under Section 8(c)(i) hereof or as individual Annual Incentive
Awards. The amount potentially payable, with respect to Annual Incentive Awards, shall be based
upon the achievement of a performance goal or goals based on one or more of the business criteria
set forth in Section 8(b)(ii) hereof in the given performance year, as specified by the Committee.

               (ii) Annual Incentive Award Pool. The Committee may establish an Annual Incentive
Award pool, which shall be an unfunded pool, for purposes of measuring performance of the Company
in connection with Annual Incentive Awards. The amount of such Annual Incentive Award pool shall
be based upon the achievement of a performance goal or goals based on one or more of the business
criteria set forth in Section 8(b)(ii) hereof during the given performance period, as specified by
the Committee in accordance with Section 8(b)(iii) hereof. The Committee may, in its discretion,
adjust the amount of such Annual Incentive Pool to reflect the events or occurrences set forth in
Section 8(b)(i). The Committee may specify the amount of the Annual Incentive Award pool as a
percentage of any of such business criteria, a percentage thereof in excess of a threshold amount,
or as another amount which need not bear a strictly mathematical relationship to such business
criteria. The Committee may, in its discretion, adjust the amount of such Annual Incentive Pool to
reflect the events or occurrences set forth in Section 8(b)(i).

               (iii) Payout of Annual Incentive Awards. After the end of each applicable year, the
Committee shall determine the amount, if any, of (A) the Annual Incentive Award pool, and the
maximum amount of the potential Annual Incentive Award payable to each Participant in the Annual
Incentive Award pool, or (B) the amount of the potential Annual Incentive Award otherwise payable
to each Participant. The Committee may, in its discretion, determine that the amount payable to
any Participant as a final Annual Incentive Award shall be reduced from the amount of his or her
potential Annual Incentive Award, including a determination to make no final Award whatsoever, but
may not exercise discretion to increase any such amount in the case of an Annual Incentive Award
intended to qualify under section 162(m) of the Code. The Committee shall specify the
circumstances in which an Annual Incentive Award shall be paid or forfeited in the event of
termination of employment by the Participant prior to the end of the applicable year or settlement
of such Annual Incentive Award.

          (d) Written Determinations. All determinations by the Committee as to the
establishment of performance goals, the amount of any Performance Award pool or potential
individual Performance Awards, the achievement of performance goals relating to and final
settlement of Performance Awards under Section 8(b), the amount of any Annual Incentive Award pool
or potential individual Annual Incentive Awards, the achievement of performance goals relating to
and final settlement of Annual Incentive Awards under Section 8(c) shall be

17

 

made in writing in the case of any Award intended to qualify under section 162(m) of the Code.
The Committee may not delegate any responsibility relating to such Performance Awards or Annual
Incentive Awards.

          (e) Status of Section 8(b) and Section 8(c) Awards under Section 162(m) of the Code.
It is the intent of the Company that Performance Awards and Annual Incentive Awards under Sections
8(b) and 8(c) hereof granted to Persons who are designated by the Committee as likely to be Covered
Employees within the meaning of section 162(m) of the Code and the regulations thereunder
(including Treasury Regulation § 1.162-27 and successor regulations thereto) shall, if so
designated by the Committee, constitute “performance-based compensation” within the meaning of
section 162(m) of the Code and regulations thereunder. Accordingly, the terms of Sections 8(b),
(c), (d) and (e), including the definitions of Covered Employee and other terms used therein, shall
be interpreted in a manner consistent with section 162(m) of the Code and regulations thereunder.
The foregoing notwithstanding, because the Committee cannot determine with certainty whether a
given Eligible Person will be a Covered Employee with respect to a fiscal year that has not yet
been completed, the term “Covered Employee” as used herein shall mean only a Person designated by
the Committee, at the time of grant of a Performance Award or Annual Incentive Award, who is likely
to be a Covered Employee with respect to that fiscal year. If any provision of this Plan as in
effect on the date of adoption of any agreements relating to Performance Awards or Annual Incentive
Awards that are designated as intended to comply with section 162(m) of the Code does not comply or
is inconsistent with the requirements of section 162(m) of the Code or regulations thereunder, such
provision shall be construed or deemed amended to the extent necessary to conform to such
requirements. Notwithstanding this Section 8(e), the Company intends to rely on the transition
relief set forth in Treasury Regulation § 1.162-27(f) until the earliest to occur of (i) the
material modification of the Plan within the meaning of Treasury Regulation § 1.162-27(h)(1)(iii);
(ii) the issuance of the number of shares of Stock set forth in Section 4(a), or (iii) the first
meeting of shareholders of the Company at which directors are to be elected that occurs after
December 31, 2013.

     9. Subdivision or Consolidation; Recapitalization; Change in Control; Reorganization.

          (a) Existence of Plans and Awards. The existence of this Plan and the Awards granted
hereunder shall not affect in any way the right or power of the Board or the stockholders of the
Company to make or authorize any adjustment, recapitalization, reorganization or other change in
the Company’s capital structure or its business, any merger or consolidation of the Company, any
issue of debt or equity securities ahead of or affecting Stock or the rights thereof, the
dissolution or liquidation of the Company or any sale, lease, exchange or other disposition of all
or any part of its assets or business or any other corporate act or proceeding. In no event will
any action taken by the Committee pursuant to this Section 9 result in the creation of deferred
compensation within the meaning of the Nonqualified Deferred Compensation Rules.

          (b) Subdivision or Consolidation of Shares. The terms of an Award and the number of
shares of Stock authorized pursuant to Section 4 for issuance under the Plan shall be subject to
adjustment from time to time, in accordance with the following provisions:

18

 

               (i) If at any time, or from time to time, the Company shall subdivide as a whole (by
reclassification, by a Stock split, by the issuance of a distribution on Stock payable in Stock, or
otherwise) the number of shares of Stock then outstanding into a greater number of shares of Stock
or in the event the Company distributes an extraordinary cash dividend, then, as appropriate, (A)
the maximum number of shares of Stock available for the Plan or in connection with Awards as
provided in Sections 4 and 5 shall be increased proportionately, and the kind of shares or other
securities available for the Plan shall be appropriately adjusted, (B) the number of shares of
Stock (or other kind of shares or securities) that may be acquired under any then outstanding Award
shall be increased proportionately, and (C) the price (including the exercise price) for each share
of Stock (or other kind of shares or securities) subject to then outstanding Awards shall be
reduced proportionately, without changing the aggregate purchase price or value as to which
outstanding Awards remain exercisable or subject to restrictions.

               (ii) If at any time, or from time to time, the Company shall consolidate as a whole (by
reclassification, by reverse Stock split, or otherwise) the number of shares of Stock then
outstanding into a lesser number of shares of Stock, (A) the maximum number of shares of Stock for
the Plan or available in connection with Awards as provided in Sections 4 and 5 shall be decreased
proportionately, and the kind of shares or other securities available for the Plan shall be
appropriately adjusted, (B) the number of shares of Stock (or other kind of shares or securities)
that may be acquired under any then outstanding Award shall be decreased proportionately, and (C)
the price (including the exercise price) for each share of Stock (or other kind of shares or
securities) subject to then outstanding Awards shall be increased proportionately, without changing
the aggregate purchase price or value as to which outstanding Awards remain exercisable or subject
to restrictions.

               (iii) Whenever the number of shares of Stock subject to outstanding Awards and the price for
each share of Stock subject to outstanding Awards are required to be adjusted as provided in this
Section 9(b), the Committee shall promptly prepare a notice setting forth, in reasonable detail,
the event requiring adjustment, the amount of the adjustment, the method by which such adjustment
was calculated, and the change in price and the number of shares of Stock, other securities, cash,
or property purchasable subject to each Award after giving effect to the adjustments. The
Committee shall promptly provide each affected Participant with such notice.

               (iv) Adjustments under Sections 9(b)(i) and (ii) shall be made by the Committee, and its
determination as to what adjustments shall be made and the extent thereof shall be final, binding,
and conclusive. No fractional interest shall be issued under the Plan on account of any such
adjustments.

          (c) Corporate Recapitalization. If the Company recapitalizes, reclassifies its
capital stock, or otherwise changes its capital structure (a “recapitalization”) without the
occurrence of a Change in Control, the number and class of shares of Stock covered by an Option or
an SAR theretofore granted shall be adjusted so that such Option or SAR shall thereafter cover the
number and class of shares of stock and securities to which the holder would have been entitled
pursuant to the terms of the recapitalization if, immediately prior to the recapitalization, the
holder had been the holder of record of the number of shares of Stock then

19

 

covered by such Option or SAR and the share limitations provided in Sections 4 and 5 shall be
adjusted in a manner consistent with the recapitalization.

          (d) Additional Issuances. Except as hereinbefore expressly provided, the issuance by
the Company of shares of stock of any class or securities convertible into shares of stock of any
class, for cash, property, labor or services, upon direct sale, upon the exercise of rights or
warrants to subscribe therefor, or upon conversion of shares or obligations of the Company
convertible into such shares or other securities, and in any case whether or not for fair value,
shall not affect, and no adjustment by reason thereof shall be made with respect to, the number of
shares of Stock subject to Awards theretofore granted or the purchase price per share, if
applicable.

          (e) Change in Control. Upon a Change in Control, the Committee, acting in its sole
discretion without the consent or approval of any holder, shall affect one or more of the following
alternatives, which may vary among individual holders and which may vary among Options or SARs
(collectively “Grants”) held by any individual holder: (i) accelerate the time at which Grants then
outstanding may be exercised so that such Grants may be exercised in full for a limited period of
time on or before a specified date (before or after such Change in Control) fixed by the Committee,
after which specified date all unexercised Grants and all rights of holders thereunder shall
terminate, (ii) require the mandatory surrender to the Company by selected holders of some or all
of the outstanding Grants held by such holders (irrespective of whether such Grants are then
exercisable under the provisions of this Plan) as of a date, before or after such Change in
Control, specified by the Committee, in which event the Committee shall thereupon cancel such
Grants and pay to each holder an amount of cash per share equal to the excess, if any, of the
amount calculated in Section 9(f) (the “Change in Control Price”) of the shares subject to such
Grants over the Exercise Price(s) under such Grants for such shares (except to the extent the
Exercise Price under any such Grant is equal to or exceeds the Change in Control Price, in which
case no amount shall be payable with respect to such Grant), or (iii) make such adjustments to
Grants then outstanding as the Committee deems appropriate to reflect such Change in Control;
provided, however, that the Committee may determine in its sole discretion that no
adjustment is necessary to Grants then outstanding; provided, further,
however, that the right to make such adjustments shall include, but not require or be
limited to, the modification of Grants such that the holder of the Grant shall be entitled to
purchase or receive (in lieu of the total number of shares of Stock as to which an Option or SAR is
exercisable (the “Total Shares”) or other consideration that the holder would otherwise be entitled
to purchase or receive under the Grant (the “Total Consideration”)), the number of shares of stock,
other securities, cash or property to which the Total Shares or Total Consideration would have been
entitled to in connection with the Change in Control (A) in the case of Options, at an aggregate
exercise price equal to the Exercise Price that would have been payable if the Total Shares had
been purchased upon the exercise of the Grant immediately before the consummation of the Change in
Control and (B) in the case of SARs, if the SARs had been exercised immediately before the
occurrence of the Change in Control.

          (f) Change in Control Price. The “Change in Control Price” shall equal the amount
determined in the following clause (i), (ii), (iii), (iv) or (v), whichever is applicable, as
follows: (i) the price per share offered to holders of Stock in any merger or consolidation, (ii)

20

 

the per share Fair Market Value of the Stock immediately before the Change in Control without
regard to assets sold in the Change in Control and assuming the Company has received the
consideration paid for the assets in the case of a sale of the assets, (iii) the amount distributed
per share of Stock in a dissolution transaction, (iv) the price per share offered to holders of
Stock in any tender offer or exchange offer whereby a Change in Control takes place, or (v) if such
Change in Control occurs other than pursuant to a transaction described in clauses (i), (ii),
(iii), or (iv) of this Section 9(f), the Fair Market Value per share of the Stock that may
otherwise be obtained with respect to such Grants or to which such Grants track, as determined by
the Committee as of the date determined by the Committee to be the date of cancellation and
surrender of such Grants. In the event that the consideration offered to stockholders of the
Company in any transaction described in this Section 9(f) or in Section 9(e) consists of anything
other than cash, the Committee shall determine the fair cash equivalent of the portion of the
consideration offered which is other than cash and such determination shall be binding on all
affected Participants to the extent applicable to Awards held by such Participants.

          (g) Impact of Corporate Events on Awards Generally. In the event of changes in the
outstanding Stock by reason of a recapitalization, reorganization, merger, consolidation,
combination, exchange or other relevant change in capitalization occurring after the date of grant
of any Award and not otherwise provided for by this Section 9, any outstanding Awards and any Award
agreements evidencing such Awards shall be subject to adjustment by the Committee at its
discretion, which adjustment may, in the Committee’s discretion, be described in the Award
agreement and may include, but not be limited to, adjustments as to the number and price of shares
of Stock or other consideration subject to such Awards, accelerated vesting (in full or in part) of
such Awards, conversion of such Awards into awards denominated in the securities or other interests
of any successor Person, or the cash settlement of such Awards in exchange for the cancellation
thereof. In the event of any such change in the outstanding Stock, the aggregate number of shares
of Stock available under this Plan may be appropriately adjusted by the Committee, whose
determination shall be conclusive

     10. General Provisions.

          (a) Transferability.

               (i) Permitted Transferees. The Committee may, in its discretion, permit a Participant
to transfer all or any portion of an Option or SAR, or authorize all or a portion of an Option or
SAR to be granted to an Eligible Person to be on terms which permit transfer by such Participant;
provided that, in either case, the transferee or transferees must be a child, stepchild,
grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew,
mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law,
including adoptive relationships, in each case with respect to the Participant, an individual
sharing the Participant’s household (other than a tenant or employee of the Company), a trust in
which any of the foregoing individuals have more than fifty percent of the beneficial interest, a
foundation in which any of the foregoing individuals (or the Participant) control the management of
assets, or any other entity in which any of the foregoing individuals (or the Participant) own more
than fifty percent of the voting interests (collectively, “Permitted Transferees”); provided
further that, (A) there may be no consideration for any such transfer and (B) subsequent transfers
of Options or SARs transferred as provided above shall be prohibited

21

 

except subsequent transfers back to the original holder of the Option or SAR and transfers to
other Permitted Transferees of the original holder. Agreements evidencing Options or SARs with
respect to which such transferability is authorized at the time of grant must be approved by the
Committee, and must expressly provide for transferability in a manner consistent with this Section
10(a)(i).

               (ii) Qualified Domestic Relations Orders. An Option, Stock Appreciation Right,
Restricted Stock Unit Award, Restricted Stock Award or other Award may be transferred, to a
Permitted Transferee, pursuant to a domestic relations order entered or approved by a court of
competent jurisdiction upon delivery to the Company of written notice of such transfer and a
certified copy of such order.

               (iii) Other Transfers. Except as expressly permitted by Sections 10(a)(i) and
10(a)(ii), Awards shall not be transferable other than by will or the laws of descent and
distribution. Notwithstanding anything to the contrary in this Section 10, an Incentive Stock
Option shall not be transferable other than by will or the laws of descent and distribution.

               (iv) Effect of Transfer. Following the transfer of any Award as contemplated by
Sections 10(a)(i), 10(a)(ii) and 10(a)(iii), (A) such Award shall continue to be subject to the
same terms and conditions as were applicable immediately prior to transfer, provided that the term
“Participant” shall be deemed to refer to the Permitted Transferee, the recipient under a qualified
domestic relations order, or the estate or heirs of a deceased Participant or other transferee, as
applicable, to the extent appropriate to enable the Participant to exercise the transferred Award
in accordance with the terms of this Plan and applicable law and (B) the provisions of the Award
relating to exercisability shall continue to be applied with respect to the original Participant
and, following the occurrence of any applicable events described therein the Awards shall be
exercisable by the Permitted Transferee, the recipient under a qualified domestic relations order,
or the estate or heirs of a deceased Participant, as applicable, only to the extent and for the
periods that would have been applicable in the absence of the transfer.

               (v) Procedures and Restrictions. Any Participant desiring to transfer an Award as
permitted under Sections 10(a)(i), 10(a)(ii) or 10(a)(iii) shall make application therefor in the
manner and time specified by the Committee and shall comply with such other requirements as the
Committee may require to assure compliance with all applicable securities laws. The Committee
shall not give permission for such a transfer if (A) it would give rise to short swing liability
under section 16(b) of the Exchange Act or (B) it may not be made in compliance with all applicable
federal, state and foreign securities laws.

               (vi) Registration. To the extent the issuance to any Permitted Transferee of any
shares of Stock issuable pursuant to Awards transferred as permitted in this Section 10(a) is not
registered pursuant to the effective registration statement of the Company generally covering the
shares to be issued pursuant to this Plan to initial holders of Awards, the Company shall not have
any obligation to register the issuance of any such shares of Stock to any such transferee.

22

 

          (b) Taxes. The Company and any of its Subsidiaries are authorized to withhold from
any Award granted, or any payment relating to an Award under this Plan, including from a
distribution of Stock, amounts of withholding and other taxes due or potentially payable in
connection with any transaction involving an Award, and to take such other action as the Committee
may deem advisable to enable the Company and Participants to satisfy obligations for the payment of
withholding taxes and other tax obligations relating to any Award. This authority shall include
authority to withhold or receive Stock or other property and to make cash payments in respect
thereof in satisfaction of a Participant’s tax obligations, either on a mandatory or elective basis
in the discretion of the Committee.

          (c) Changes to this Plan and Awards. The Board may amend, alter, suspend, discontinue
or terminate this Plan or the Committee’s authority to grant Awards under this Plan without the
consent of stockholders or Participants, except that any amendment or alteration to this Plan,
including any increase in any share limitation, shall be subject to the approval of the Company’s
stockholders not later than the annual meeting next following such Board action if such stockholder
approval is required by any federal or state law or regulation or the rules of any stock exchange
or automated quotation system on which the Stock may then be listed or quoted, and the Board may
otherwise, in its discretion, determine to submit other such changes to this Plan to stockholders
for approval; provided, that, without the consent of an affected Participant, no such Board action
may materially and adversely affect the rights of such Participant under any previously granted and
outstanding Award. The Committee may waive any conditions or rights under, or amend, alter,
suspend, discontinue or terminate any Award theretofore granted and any Award agreement relating
thereto, except as otherwise provided in this Plan; provided, however, that,
without the consent of an affected Participant, no such Committee action may materially and
adversely affect the rights of such Participant under such Award. For purposes of clarity, any
adjustments made to Awards pursuant to Section 9 will be deemed not to materially and adversely
affect the rights of any Participant under any previously granted and outstanding Award and
therefore may be made without the consent of affected Participants.

          (d) Limitation on Rights Conferred under Plan. Neither this Plan nor any action taken
hereunder shall be construed as (i) giving any Eligible Person or Participant the right to continue
as an Eligible Person or Participant or in the employ or service of the Company or any of its
Subsidiaries, (ii) interfering in any way with the right of the Company or any of its Subsidiaries
to terminate any Eligible Person’s or Participant’s employment or service relationship at any time,
(iii) giving an Eligible Person or Participant any claim to be granted any Award under this Plan or
to be treated uniformly with other Participants and/or employees and/or other service providers, or
(iv) conferring on a Participant any of the rights of a stockholder of the Company unless and until
the Participant is duly issued or transferred shares of Stock in accordance with the terms of an
Award.

          (e) Unfunded Status of Awards. This Plan is intended to constitute an “unfunded” plan
for certain incentive awards.

          (f) Nonexclusivity of this Plan. Neither the adoption of this Plan by the Board nor
its submission to the stockholders of the Company for approval shall be construed as creating any
limitations on the power of the Board or a committee thereof to adopt such other incentive
arrangements as it may deem desirable, including incentive arrangements and awards

23

 

which do not qualify under section 162(m) of the Code. Nothing contained in this Plan shall
be construed to prevent the Company or any of its Subsidiaries from taking any corporate action
which is deemed by the Company or such Subsidiary to be appropriate or in its best interest,
whether or not such action would have an adverse effect on this Plan or any Award made under this
Plan. No employee, beneficiary or other person shall have any claim against the Company or any of
its Subsidiaries as a result of any such action.

          (g) Fractional Shares. No fractional shares of Stock shall be issued or delivered
pursuant to this Plan or any Award. The Committee shall determine whether cash, other Awards or
other property shall be issued or paid in lieu of such fractional shares or whether such fractional
shares or any rights thereto shall be forfeited or otherwise eliminated.

          (h) Severability. If any provision of this Plan is held to be illegal or invalid for
any reason, the illegality or invalidity shall not affect the remaining provisions hereof, but such
provision shall be fully severable and the Plan shall be construed and enforced as if the illegal
or invalid provision had never been included herein. If any of the terms or provisions of this
Plan or any Award agreement conflict with the requirements of Rule 16b-3 (as those terms or
provisions are applied to Eligible Persons who are subject to section 16(b) of the Exchange Act) or
section 422 of the Code (with respect to Incentive Stock Options), then those conflicting terms or
provisions shall be deemed inoperative to the extent they so conflict with the requirements of Rule
16b-3 (unless the Board or Committee, as appropriate, has expressly determined that the Plan or
such Award should not comply with Rule 16b-3) or section 422 of the Code. With respect to
Incentive Stock Options, if this Plan does not contain any provision required to be included herein
under section 422 of the Code, that provision shall be deemed to be incorporated herein with the
same force and effect as if that provision had been set out at length herein; provided, further,
that, to the extent any Option that is intended to qualify as an Incentive Stock Option cannot so
qualify, that Option (to that extent) shall be deemed an Option not subject to section 422 of the
Code for all purposes of the Plan.

          (i) Governing Law. All questions arising with respect to the provisions of the Plan
and Awards shall be determined by application of the laws of the State of Texas, without giving
effect to any conflict of law provisions thereof, except to the extent Texas state law is preempted
by federal law. The obligation of the Company to sell and deliver Stock hereunder is subject to
applicable federal and state laws and to the approval of any governmental authority required in
connection with the authorization, issuance, sale, or delivery of such Stock.

          (j) Conditions to Delivery of Stock. Nothing herein or in any Award granted hereunder
or any Award agreement shall require the Company to issue any shares with respect to any Award if
that issuance would, in the opinion of counsel for the Company, constitute a violation of the
Securities Act or any similar or superseding statute or statutes, any other applicable statute or
regulation, or the rules of any applicable securities exchange or securities association, as then
in effect. At the time of any exercise of an Option or Stock Appreciation Right, or at the time of
any grant of a Restricted Stock Award, Restricted Stock Unit, or other Award the Company may, as a
condition precedent to the exercise of such Option or Stock Appreciation Right or settlement of any
Restricted Stock Award, Restricted Stock Unit or other Award, require from the Participant (or in
the event of his or her death, his or her legal representatives, heirs, legatees, or distributees)
such written representations, if any, concerning

24

 

the holder’s intentions with regard to the retention or disposition of the shares of Stock
being acquired pursuant to the Award and such written covenants and agreements, if any, as to the
manner of disposal of such shares as, in the opinion of counsel to the Company, may be necessary to
ensure that any disposition by that holder (or in the event of the holder’s death, his or her legal
representatives, heirs, legatees, or distributees) will not involve a violation of the Securities
Act or any similar or superseding statute or statutes, any other applicable state or federal
statute or regulation, or any rule of any applicable securities exchange or securities association,
as then in effect. No Option or Stock Appreciation Right shall be exercisable and no settlement of
any Restricted Stock Award or Restricted Stock Unit shall occur with respect to a Participant
unless and until the holder thereof shall have paid cash or property to, or performed services for,
the Company or any of its Subsidiaries that the Committee believes is equal to or greater in value
than the par value of the Stock subject to such Award.

          (k) Section 409A of the Code. In the event that any Award granted pursuant to this
Plan provides for a deferral of compensation within the meaning of the Nonqualified Deferred
Compensation Rules, such Award will be designed to comply with the Nonqualified Deferred
Compensation Rules.

          (l) Plan Effective Date and Term. This Plan was adopted by the Board on March 12,
2010 and approved by the stockholders of the Company on March 12, 2010 to be effective as of the
Effective Date. No Awards may be granted under this Plan on and after March 12, 2020.

25

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}]]